Mereo BioPharma MREO
NASDAQ MREO
$0.31 +0.01 (+2.92%)
At close: Nov 11, 2026 · 4:00 PM EST

Mereo BioPharma (MREO) Capital Expenditures (2025)

Updated

Mereo BioPharma's Capital Expenditures came in at $20,000 for FY2025.

Analysis

Mereo BioPharma (MREO) Capital Expenditures (2025) Analysis & Trends

Going back to FY2016, Mereo BioPharma's Capital Expenditures data covers 8 years.

  • Capital Expenditures carries a five-year compound annual growth rate of -1.1% (FY2020 to FY2025).
  • The FY2025 figure represents the highest annual Capital Expenditures since FY2021.
  • Per Business Quant, earlier years put Capital Expenditures at $13,000 in FY2022 (-98.2%) and $721,186 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.18 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.36 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 301.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.04 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -3.30 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 237.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 573.00 Mn
10 Mereo BioPharma 47.91 Mn -79.40 Mn 800,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 20,000.00
API Access

Mereo BioPharma Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=MREO&period=max&api_key=YOUR_API_KEY